Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amgen (NQ: AMGN )

245.37 +2.28 (+0.94%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 24, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,527,677
Open 244.00
Bid (Size) 243.50 (1)
Ask (Size) 246.49 (1)
Prev. Close 243.09
Today's Range 242.88 - 246.00
52wk Range 198.64 - 258.45
Shares Outstanding N/A
Dividend Yield 2.87%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
$100 Invested In Amgen 15 Years Ago Would Be Worth This Much Today
Amgen (NASDAQ:AMGN) has outperformed the market over the past 15 years by 3.97% on an annualized basis producing an average annual return of 10.41%. Currently, Amgen has a market capitalization of... 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga

Performance

YTD
+8.24%
+8.24%
1 Month
-3.02%
-3.02%
3 Month
+2.76%
+2.76%
6 Month
+8.97%
+8.97%
1 Year
+1.83%
+1.83%

More News

Read More
7 Dividend Stocks to Buy for Your Grandkids
Via InvestorPlace
We're Looking At Obesity In A New Way — And 4 Pharmaceutical Stocks Could Benefit
Via Investor's Business Daily
How Is The Market Feeling About Amgen?
Via Benzinga
Analyst Ratings for Amgen
Via Benzinga
7 of the Hottest ETFs to Buy Right Now
Via InvestorPlace
$100 Invested In Amgen 20 Years Ago Would Be Worth This Much Today
Via Benzinga
The Surprising Way Mirati Therapeutics Is Angling To Rival Amgen — And Could Succeed
Via Investor's Business Daily
Rising Yields And A Stronger Dollar Pose Risk For Stocks
Via Benzinga
Rising Cases Of Mental Health Disorders of Stress, Anxiety & Addiction Fueling Need for Central Nervous System Therapeutics
Via FinancialNewsMedia
Exposures COVID-19
Dow Finishes Flat as Surging Bond Yields Weigh
Via Talk Markets
AskSlim Market Week - Friday, June 3
Via Talk Markets
Stocks Pacing for Weekly Losses Despite Strong Jobs Data
Via Talk Markets
Stocks Snap Losing Streaks as VIX Inches Lower
Via Talk Markets
Oncolytics Reports Partnering With Biopharma Industry Leaders To Fast-Track Immunotherapy Treatment
Via Benzinga
$100 Invested In Amgen 15 Years Ago Would Be Worth This Much
Via Benzinga
Mirati Therapeutics Plunges As Its Hopes To Take On Amgen In Lung Cancer Crash
Via Investor's Business Daily
Quant Ratings Updated on 75 Stocks
Via InvestorPlace
7 Retirement Stocks to Buy to Turbocharge Your Savings
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2022
Via Benzinga
7 Cheap Biotech Stocks to Buy Now
Via InvestorPlace
How Heart Drugs Could Pump $10 Billion Into Merck's Coffers
Via Investor's Business Daily
7 Dividend Stocks to Boost Your Retirement Savings
Via InvestorPlace
Peering Into Amgen's Recent Short Interest
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.